These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9088525)

  • 1. Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).
    van Gestel AM; Haagsma CJ; Furst DE; van Riel PL
    Baillieres Clin Rheumatol; 1997 Feb; 11(1):65-82. PubMed ID: 9088525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach to rheumatoid arthritis].
    Breedveld FC
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):717-9. PubMed ID: 9213787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.
    van der Heide A; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; van der Veen MJ; Haanen HC; Hofman DM; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Dinant HJ; Kruize AA; Schenk Y
    Ann Intern Med; 1996 Apr; 124(8):699-707. PubMed ID: 8633829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
    Danis VA; Franic GM; Brooks PM
    Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW
    Rheumatology (Oxford); 2000 Dec; 39(12):1374-82. PubMed ID: 11136881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are slow-acting anti-rheumatic drugs monitored too often? An audit of current clinical practice.
    Comer M; Scott DL; Doyle DV; Huskisson EC; Hopkins A
    Br J Rheumatol; 1995 Oct; 34(10):966-70. PubMed ID: 7582705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities.
    Blackburn WD
    Am J Med; 1996 Feb; 100(2A):24S-30S. PubMed ID: 8604723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-acting antirheumatic drugs. Drug interactions of clinical significance.
    Munro RA; Sturrock RD
    Drug Saf; 1995 Jul; 13(1):25-30. PubMed ID: 8527017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of standard slow-acting antirheumatic drugs.
    Epstein WV
    Semin Arthritis Rheum; 1994 Jun; 23(6 Suppl 2):32-8. PubMed ID: 7939729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favorable results of early 2nd-stage medication in rheumatoid arthritis].
    van Jaarsveld CH; van der Heide A
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):732-6. PubMed ID: 9213790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy in rheumatoid arthritis.
    Brooks PM
    Agents Actions Suppl; 1993; 44():95-103. PubMed ID: 8372740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
    van Jaarsveld CH; Jacobs JW; van der Veen MJ; Blaauw AA; Kruize AA; Hofman DM; Brus HL; van Albada-Kuipers GA; Heurkens AH; ter Borg EJ; Haanen HC; van Booma-Frankfort C; Schenk Y; Bijlsma JW
    Ann Rheum Dis; 2000 Jun; 59(6):468-77. PubMed ID: 10834865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.
    Capell HA; Brzeski M
    Ann Rheum Dis; 1992 Mar; 51(3):424-9. PubMed ID: 1575601
    [No Abstract]   [Full Text] [Related]  

  • 17. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.
    Möttönen T; Paimela L; Leirisalo-Repo M; Kautiainen H; Ilonen J; Hannonen P
    Ann Rheum Dis; 1998 Sep; 57(9):533-9. PubMed ID: 9849312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A history of the term "DMARD".
    Buer JK
    Inflammopharmacology; 2015 Aug; 23(4):163-71. PubMed ID: 26002695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of rheumatoid arthritis].
    Halberg P
    Ugeskr Laeger; 1993 Jul; 155(30):2319-23. PubMed ID: 8102215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
    Simpson E; Hock E; Stevenson M; Wong R; Dracup N; Wailoo A; Conaghan P; Estrach C; Edwards C; Wakefield R
    Health Technol Assess; 2018 Apr; 22(20):1-258. PubMed ID: 29712616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.